500 related articles for article (PubMed ID: 23103194)
1. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine.
Riddell M; Senn N; Clements CJ; Hobday L; Cowie B; Kurubi J; Kevin A; Siba P; Reeder JC; Morgan C
Vaccine; 2012 Dec; 30(52):7506-12. PubMed ID: 23103194
[TBL] [Abstract][Full Text] [Related]
2. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
Lacapère F; Magloire R; Danovaro-Holliday MC; Flannery B; Chamoulliet H; Celestin EP
J Infect Dis; 2011 Sep; 204 Suppl 2():S698-705. PubMed ID: 21954269
[TBL] [Abstract][Full Text] [Related]
3. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination.
Rainey JJ; Danovaro-Holliday MC; Magloire R; Kananda G; Lee CE; Chamouillet H; Lacapere F; Mung K; Luman ET
J Infect Dis; 2011 Sep; 204 Suppl 2():S616-21. PubMed ID: 21954256
[TBL] [Abstract][Full Text] [Related]
4. Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001-2008.
Castillo-Solórzano C; Reef SE; Morice A; Vascones N; Chevez AE; Castalia-Soares R; Torres C; Vizzotti C; Ruiz Matus C
J Infect Dis; 2011 Sep; 204 Suppl 2():S713-7. PubMed ID: 21954271
[TBL] [Abstract][Full Text] [Related]
5. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
6. Congenital rubella syndrome in infants of women vaccinated during or just before pregnancy with measles-rubella vaccine.
Namaei MH; Ziaee M; Naseh N
Indian J Med Res; 2008 Jun; 127(6):551-4. PubMed ID: 18765873
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].
Buxbaum S; Doerr HW; Allwinn R
Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730
[TBL] [Abstract][Full Text] [Related]
8. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
Kremer JR; Schneider F; Muller CP
Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
[TBL] [Abstract][Full Text] [Related]
9. Measles, mumps and rubella: control by vaccination.
van Druten JA; de Boo T; Plantinga AD
Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
[TBL] [Abstract][Full Text] [Related]
10. Progress in measles and rubella elimination in Iran.
Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
[TBL] [Abstract][Full Text] [Related]
11. Rubella seroprevalence among women of childbearing age residing in a rural region: is there a need for rubella vaccination in Turkey?
Aksakal FN; Maral I; Cirak MY; Aygun R
Jpn J Infect Dis; 2007 Jul; 60(4):157-60. PubMed ID: 17642522
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil.
Minussi L; Mohrdieck R; Bercini M; Ranieri T; Sanseverino MT; Momino W; Callegari-Jacques SM; Schuler-Faccini L
Reprod Toxicol; 2008 Jan; 25(1):120-3. PubMed ID: 17977696
[TBL] [Abstract][Full Text] [Related]
13. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcomes following rubella vaccination: a prospective study in the state of Rio de Janeiro, Brazil, 2001-2002.
da Silva e Sá GR; Camacho LA; Stavola MS; Lemos XR; Basílio de Oliveira CA; Siqueira MM
J Infect Dis; 2011 Sep; 204 Suppl 2():S722-8. PubMed ID: 21954273
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial.
Kohler KA; Suleiman AJ; Robertson SE; Malankar P; Al-Khusaiby S; Helfand RF; Brown D; Bellini WJ; Sutter RW
J Infect Dis; 2003 May; 187 Suppl 1():S177-85. PubMed ID: 12721911
[TBL] [Abstract][Full Text] [Related]
16. Targeting rubella for elimination.
Taneja DK; Sharma P
Indian J Public Health; 2012; 56(4):269-72. PubMed ID: 23354136
[TBL] [Abstract][Full Text] [Related]
17. Serologic status of women in an urban population in Brazil before and after rubella immunization campaign using routine screening data.
Artimos de Oliveira S; Bastos Camacho LA; Uzeda Barreto MC; Coca Velarde LG; Siqueira MM
J Infect Dis; 2011 Sep; 204 Suppl 2():S664-8. PubMed ID: 21954264
[TBL] [Abstract][Full Text] [Related]
18. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?
Hyde TB; Kruszon-Moran D; McQuillan GM; Cossen C; Forghani B; Reef SE
Clin Infect Dis; 2006 Nov; 43 Suppl 3():S146-50. PubMed ID: 16998774
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
Miller E; Waight P; Gay N; Ramsay M; Vurdien J; Morgan-Capner P; Hesketh L; Brown D; Tookey P; Peckham C
Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R26-32. PubMed ID: 9046126
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
Tseng HF; Chang CK; Tan HF; Yang SE; Chang HW
Vaccine; 2006 Jul; 24(29-30):5772-7. PubMed ID: 16759764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
